NEW YORK, Feb. 17, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of bluebird bio, Inc. (NASDAQ: BLUE) between May 11, 2020 and November 4, 2020, inclusive (the "Class...
from PR Newswire: https://ift.tt/3b8B2Je
No comments:
Post a Comment